Skip to main content

What the FDA labels say about taking them together

Atorvastatin and digoxin

Atorvastatin's FDA label of April 15, 2024 names digoxin in its drug interactions section; the digoxin labels PlainMeds reads (3) do not name atorvastatin. The atorvastatin label: “May increase digoxin plasma levels; monitor patients appropriately.”

Check it at the source: the atorvastatin FDA label on DailyMed (effective April 15, 2024, Viatris Specialty LLC); the digoxin FDA label on DailyMed (effective December 5, 2024, Advanz Pharma (US) Corp.).

What does the atorvastatin label say about digoxin?

Atorvastatin label, drug interactions

May increase digoxin plasma levels; monitor patients appropriately ( 7.3 ).

Source: FDA drug label (Lipitor), NDA020702 (Upjohn), as published by Viatris Specialty LLC, effective April 15, 2024 (SPL set a60cc18b-0631-4cf0-b021-9f52224ece65), via openFDA; the full label on DailyMed

What does the digoxin label say about atorvastatin?

Digoxin's label (effective December 5, 2024) and its 2 other brand-application labels do not name atorvastatin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (LANOXIN), Advanz Pharma (US) Corp., effective December 5, 2024 (SPL set d91e3646-4c63-4512-ab22-db39c085c4dc), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

59Atorvastatin generic labelers
26Digoxin generic labelers
AtorvastatinDigoxin
Labeled forHigh cholesterol, Angina, High triglycerides, Heart attack and coronary artery diseaseHeart failure, Atrial fibrillation
Boxed warningNoNo
Pharmacy cost (NADAC)$0.0228 per tablet 10 mg tablet$0.133 per tablet 125 mcg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?